NexgenRx Inc logo

NXG - NexgenRx Inc Share Price

C$0.17 0.0  0.0%

Last Trade - 23/09/20

Sector
Financials
Size
Micro Cap
Market Cap £6.97m
Enterprise Value £8.59m
Revenue £5.91m
Position in Universe 1583rd / 2682
Bullish
Bearish
Unlock NXG Revenue
Momentum
Relative Strength (%)
1m -5.92%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -48.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
4.22 4.69 5.75 5.67 7.17 9.54 +17.7%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, NexgenRx Inc. revenues increased 11% to C$5.3M. Net income increased from C$73K to C$764K. Revenues reflect Administration fees increase of 26% to C$1.9M, Other Income increase from C$97K to C$429K, Transaction fees increase of 8% to C$2.6M. Net income benefited from Marketing decrease of 58% to C$143K (expense), Compensation and external contractors decrease of 3% to C$2.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NXG Revenue Unlock NXG Revenue

Net Income

NXG Net Income Unlock NXG Revenue

Normalised EPS

NXG Normalised EPS Unlock NXG Revenue

PE Ratio Range

NXG PE Ratio Range Unlock NXG Revenue

Dividend Yield Range

NXG Dividend Yield Range Unlock NXG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
NXG EPS Forecasts Unlock NXG Revenue
Profile Summary

NexgenRx Inc. (NexgenRx) administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using computer software. The Company is engaged in the sale of its administration and health benefit claims adjudication services to organizations managing health benefit plans on behalf of plan sponsors, such as employers and associations, among others, and to the Canadian plan sponsors providing an Administrative Services Only (ASO) health benefit plan to their plan members. The health benefit claims include drug, dental, extended health and healthcare spending account claims. The Company sells its service on a fee-per-transaction basis, in addition to per member administration fees. The Company's Web-based product, theclaimsXchange.com, offers a platform, which allows various extended health providers to submit claims on behalf of their patients for benefits through a Web portal.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated March 13, 2003
Public Since July 25, 2000
No. of Shareholders: n/a
No. of Employees: 20
Sector Financials
Industry Insurance
Index
Exchange TSX Venture Exchange
Shares in Issue 69,919,216
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NXG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NXG
Upcoming Events for NXG
Frequently Asked Questions for NexgenRx Inc
What is the NexgenRx Inc share price?

As of 23/09/20, shares in NexgenRx Inc are trading at C$0.17, giving the company a market capitalisation of £6.97m. This share price information is delayed by 15 minutes.

How has the NexgenRx Inc share price performed this year?

Shares in NexgenRx Inc are currently trading at C$0.17 and the price has moved by -22.73% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the NexgenRx Inc price has moved by -18.93% over the past year.

What are the analyst and broker recommendations for NexgenRx Inc?

There are no analysts currently covering NexgenRx Inc.

When will NexgenRx Inc next release its financial results?

NexgenRx Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the NexgenRx Inc dividend yield?

NexgenRx Inc does not currently pay a dividend.

Does NexgenRx Inc pay a dividend?

NexgenRx Inc does not currently pay a dividend.

When does NexgenRx Inc next pay dividends?

NexgenRx Inc does not currently pay a dividend.

How do I buy NexgenRx Inc shares?

To buy shares in NexgenRx Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of NexgenRx Inc?

Shares in NexgenRx Inc are currently trading at C$0.17, giving the company a market capitalisation of £6.97m.

Where are NexgenRx Inc shares listed? Where are NexgenRx Inc shares listed?

Here are the trading details for NexgenRx Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: NXG
What kind of share is NexgenRx Inc?

Based on an overall assessment of its quality, value and momentum, NexgenRx Inc is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a NexgenRx Inc share price forecast 2020?

We were not able to load any forecast data for NexgenRx Inc.

How can I tell whether the NexgenRx Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NexgenRx Inc. Over the past six months, the relative strength of its shares against the market has been -30.35%. At the current price of C$0.17, shares in NexgenRx Inc are trading at -25.79% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the NexgenRx Inc PE Ratio?

The NexgenRx Inc PE ratio based on its reported earnings over the past 12 months is 24.64. The shares are currently trading at C$0.17.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of NexgenRx Inc?

NexgenRx Inc's management team is headed by:

Ronald Loucks - PRE
Thomas Corcoran - CHM
Ralph Soberano - DRC
Patrick Crowley - DRC
Barry Reiter - DRC
Kelly Ehler - CFO
Randy McGlynn - DRC
Who are the major shareholders of NexgenRx Inc?

Here are the top five shareholders of NexgenRx Inc based on the size of their shareholding:

Crossett (Paul Everett) Individual Investor
Percentage owned: 18.61% (13.0m shares)
Loucks (Ronald C) Individual Investor
Percentage owned: 10.49% (7.34m shares)
Burns (Charles) Individual Investor
Percentage owned: 5.51% (3.86m shares)
Rosenkrantz (David A) Individual Investor
Percentage owned: 1.04% (730k shares)
Corcoran (Thomas F) Individual Investor
Percentage owned: 0.89% (625k shares)
Similar to NXG
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.